This resolution urges the Director of the Food and Drug Administration (FDA) to undertake a comprehensive reevaluation of the safety of all chemical abortion drugs . This call is made in light of recent independent studies that suggest a significantly higher rate of serious complications than currently reported, alongside concerns about expanded access under previous administrations. The resolution highlights that chemical abortions now constitute over half of all abortions in the United States, with expanded access raising issues regarding potential violations of federal law, increased risks of coercion, and intentional misuse. It specifically requests the FDA to publicly release a full safety review of these drugs, incorporating real-world outcomes and complications to address these growing concerns.